BeyondSpring Inc. (Nasdaq: BYSI) to Ring The Nasdaq Stock Market Opening Bell
March 09 2017 - 6:00AM
What: BeyondSpring Inc.
(Nasdaq:BYSI), a global clinical stage biopharmaceutical company
focused on the development of innovative immuno-oncology cancer
therapies, will visit the Nasdaq MarketSite in Times Square, in
celebration of its initial public offering (IPO).
In honor of the occasion, Lan Huang, Ph.D.,
Co-Founder, Chairman & CEO, will ring the Opening
Bell.
Where:Nasdaq MarketSite – 4 Times
Square – 43rd & Broadway – Broadcast Studio
When:Thursday, March 9, 2017 –
9:15 a.m. to 9:30 a.m. ET
BeyondSpring Media Contact:Caitlin
Kasunich(212) 896-1241ckasunich@kcsa.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line
(Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811
Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia
features such as exclusive content, photo postings, status updates
and video of bell ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit
our Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please
visit our YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos,
please visit our Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the
Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or
http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution
photograph of the Market Open, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market open of your choice.
About BeyondSpring
BeyondSpring is a global clinical stage biopharmaceutical
company developing innovative immuno-oncology cancer therapies with
a robust pipeline from internal development and from collaboration
with Fred Hutchinson Cancer Research Center and University of
Washington. BeyondSpring has advanced its lead asset, Plinabulin,
into a Phase 3 clinical trial as a direct anticancer agent in
non-small cell lung cancer. The Company is also planning a Phase
2/3 clinical trial for Plinabulin in the prevention of
chemotherapy-induced Neutropenia. BeyondSpring’s experienced
management team brought a combined 30+ drugs to market.
About NasdaqNasdaq (Nasdaq:NDAQ)
is a leading provider of trading, clearing, exchange technology,
listing, information and public company services across six
continents. Through its diverse portfolio of solutions, Nasdaq
enables clients to plan, optimize and execute their business vision
with confidence, using proven technologies that provide
transparency and insight for navigating today's global capital
markets. As the creator of the world's first electronic stock
market, its technology powers more than 85 marketplaces in 50
countries, and 1 in 10 of the world's securities transactions.
Nasdaq is home to approximately 3,800 listed companies with a
market value of $10.1 trillion and nearly 18,000 corporate clients.
To learn more, visit: business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Sep 2023 to Sep 2024